Journal articles
Akerman A; Fichter C; Milogiannakis V; Esneau C; Silva MR; Ison T; Lopez JA; Naing Z; Caguicla J; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Boss T; Condylios A; Yeang M; Sato K; Bartlett NN; Darley D; Matthews G; Stark DJ; Promsri S; Rawlinson WD; Murrell B; Kelleher AD; Dwyer D; Sintchenko V; Kok J; Ellis S; Marris K; Knight E; Hoad VC; Irving DO; Gosbell I; Brilot F; Wood J; Aggarwal A; Turville SG, 2024, 'Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic', Ebiomedicine, 110, http://dx.doi.org/10.1016/j.ebiom.2024.105415
Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, pp. 3315, http://dx.doi.org/10.1038/s41467-024-47720-8
Cross GB; Sari IP; Burkill SM; Yap CW; Nguyen H; Quyet D; Dalay VB; Gutierrez E; Balanag VM; Castillo RJ; Chang CC; Kelleher AD; O’Doherty J; Paton NI, 2024, 'PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-54419-3
Kelly-Hanku A; Songtaweesin WN; Palmares ML; Bartlett AW; Gare J; Sta Maria MK; Thanh Thuy CT; Gideon N; Boma GV; Kaima P; Da Silva De Jesus B; Devi R; Kelleher AD; Puthanakit T, 2024, 'The urgency of now to end HIV vertical transmission for pregnant and breastfeeding women and their children in Asia and the Pacific', Lancet Regional Health Western Pacific, 53, http://dx.doi.org/10.1016/j.lanwpc.2024.101248
Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Templeton DJ; Zablotska-Manos I; Hoy J; Bloch M; Baker D; Brown G; Grulich A; Bavinton B; Pinto AN; Orth D; Roth N; Moore R; Tee BK; Pell C; McNulty A; Doong N; Triffitt K; Koelsch KK; Wilson D; Emery S; Kelleher A; Cooper DA; Grinsztejn B; Zablotska IB, 2024, 'Condom Failure Among HIV-Negative Men in Serodiscordant Relationships in Australia, Brazil, and Thailand', AIDS and Behavior, 28, pp. 3587 - 3595, http://dx.doi.org/10.1007/s10461-024-04431-x
Horsburgh BA; Walker GJ; Kelleher A; Lloyd AR; Bull RA; Giallonardo FD, 2024, 'Next-Generation Sequencing Methods for Near-Real-Time Molecular Epidemiology of HIV and HCV', Reviews in Medical Virology, 34, http://dx.doi.org/10.1002/rmv.70001
Wang TT; Hirons A; Doerflinger M; Morris KV; Ledger S; Purcell DFJ; Kelleher AD; Ahlenstiel CL, 2024, 'Current State of Therapeutics for HTLV-1', Viruses, 16, http://dx.doi.org/10.3390/v16101616
Matthews G; Jacoby S; Borok M; Eriobu N; Kaplan R; Kumarasamy N; Bennet JA; Avihingsanon A; Chetchotisakd P; Wagner Cardoso S; Azwa I; Losso M; Brown D; Arlinda D; Hutchinson J; Kelleher A; Cisse M; Dao S; Polizzotto M; Emery S; Law M; Papot E; Karyana M; Lupo S; Solari AM; Grinsztejn B; Wolff M; Andrade-Villanueva J; Mosqueda Gómez JL; Chow TS; Mohapi L; Yunihastuti E; Hadi U; Katu S; Subronto YW; Lane HC; Perelis L, 2024, 'Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial', Lancet HIV, 11, pp. e436 - e448, http://dx.doi.org/10.1016/S2352-3018(24)00089-4
King JM; Giallonardo FD; Shaik A; McGregor S; Yeung JYK; Sivaruban T; Lee FJ; Cunningham P; Dwyer DE; Nigro SJ; Grulich AE; Kelleher AD, 2024, 'Low HIV drug resistance prevalence among recently diagnosed HIV-positive men who have sex with men in a setting of high PrEP use', Journal of the International AIDS Society, 27, http://dx.doi.org/10.1002/jia2.26308
Jensen TO; Murray TA; Grandits GA; Jain MK; Grund B; Shaw-Saliba K; Matthay MA; Abassi M; Ardelt M; Baker JV; Chen P; Dewar RL; Goodman AL; Hatlen TJ; Highbarger HC; Holodniy M; Lallemand P; Laverdure S; Leshnower BG; Looney D; Moschopoulos CD; Mugerwa H; Murray DD; Mylonakis E; Nagy-Agren S; Rehman MT; Rupert A; Stevens R; Turville S; Weintrob A; Wick K; Lundgren J; Ko ER; Sahner D; Tierney J; Vogel SE; Herpin BR; Smolskis MC; McKay LA; Cahill K; Crew P; Sardana R; Raim SS; Hensely L; Lorenzo J; Mock R; Zuckerman J; Atri N; Miller M; Vallee D; Chung L; Kang N; Barrett K; Adam SJ; Read S; Draghia-Akli R; Currier J; Hughes E; Harrigan RH; Amos L; Carlsen A; Carter A; Collins G; Davis B; Denning E; DuChene A; Eckroth K; Engen N; Frase A; Gandits G; Harrison M; Hurlbut N; Kaiser P; Koopmeiners J; Larson G; Meger S; Mistry SS; Murray T; Nelson R; Quan K; Quan SF; Reilly C; Siegel L; Thompson G; Vock D; Walski J; Gelijns AC; Moskowitz AJ; Bagiella E; Moquete E; O'Sullivan K; Marks ME; Accardi E; Kinzel E; Burris S; Bedoya G; Gupta L; Overbey JR; Santos M; Gillinov MA, 2024, 'Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study', Lancet Microbe, 5, pp. e559 - e569, http://dx.doi.org/10.1016/S2666-5247(24)00015-6
Alagaratnam J; Stöhr W; Hamlyn E; Porter K; Toombs J; Heslegrave A; Zetterberg H; Gisslén M; Underwood J; Schechter M; Kaleebu P; Tambussi G; Kinloch S; Miro JM; Kelleher AD; Babiker A; Frater J; Winston A; Fidler S, 2024, 'Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial', Journal of Virus Eradication, 10, http://dx.doi.org/10.1016/j.jve.2024.100381
Cross GB; O’ Doherty J; Chang CC; Kelleher AD; Paton NI, 2024, 'Does PET-CT Have a Role in the Evaluation of Tuberculosis Treatment in Phase 2 Clinical Trials', Journal of Infectious Diseases, 229, pp. 1229 - 1238, http://dx.doi.org/10.1093/infdis/jiad425
Kitawi R; Ledger S; Kelleher AD; Ahlenstiel CL, 2024, 'Advances in HIV Gene Therapy', International Journal of Molecular Sciences, 25, http://dx.doi.org/10.3390/ijms25052771
Obeng BM; Kelleher AD; Di Giallonardo F, 2024, 'Molecular epidemiology to aid virtual elimination of HIV transmission in Australia', Virus Research, 341, http://dx.doi.org/10.1016/j.virusres.2024.199310
Chaganti J; Poudel G; Cysique LA; Dore GJ; Kelleher A; Matthews G; Darley D; Byrne A; Jakabek D; Zhang X; Lewis M; Jha N; Brew BJ, 2024, 'Blood brain barrier disruption and glutamatergic excitotoxicity in post-acute sequelae of SARS COV-2 infection cognitive impairment: potential biomarkers and a window into pathogenesis', Frontiers in Neurology, 15, http://dx.doi.org/10.3389/fneur.2024.1350848
Duette G; Marin-Rojas J; Cronin S; Deeks SG; Kelleher AD; Palmer S, 2024, '4.5 – 00020 Control of HIV infection is associated with enhanced CD8T cell functionality during consecutive analytical treatment interruptions', Journal of Virus Eradication, 10, pp. 15 - 16, http://dx.doi.org/10.1016/j.jve.2024.100416
Cronin S; Casanova AP; Vahlas Z; Lee E; Fisher K; de Vries-Egan A; Sharabas M; Kelleher A; Vérollet C; Balboa L; Palmer S; Duette G, 2024, '7.6 – 00052 The Tuberculosis Associated Microenvironment Reduces CD8+ TCell Control of HIV at the Site of the Coinfection', Journal of Virus Eradication, 10, pp. 28 - 28, http://dx.doi.org/10.1016/j.jve.2024.100435
Kelleher AD; Crowe S; Cunningham A, 2024, 'David Albert Cooper 1949–2018', Historical Records of Australian Science, http://dx.doi.org/10.1071/hr23032
Pathmanandavel K; Le S; Xie S; Alves M; Foley E; Kelleher A; Zaunders J; Carr A; Tong W; Breit S; Sewell W; Kane A, 2024, 'Novel clinical applications of functional assays to measure antigen-specific cellular immunity', Pathology, 56, pp. s27 - s27, http://dx.doi.org/10.1016/j.pathol.2023.12.101
Rouet R; Henry JY; Johansen MD; Sobti M; Balachandran H; Langley DB; Walker GJ; Lenthall H; Jackson J; Ubiparipovic S; Mazigi O; Schofield P; Burnett DL; Brown SHJ; Martinello M; Hudson B; Gilroy N; Post JJ; Kelleher A; Jäck HM; Goodnow CC; Turville SG; Rawlinson WD; Bull RA; Stewart AG; Hansbro PM; Christ D, 2023, 'Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients', Nature Communications, 14, http://dx.doi.org/10.1038/s41467-023-36295-5
Dharan NJ; Sasson SC; Ahlenstiel G; Andersen CR; Bloch M; Buckland G; Hamad N; Han WM; Kelleher AD; Long GV; Matthews GV; Mina MM; Papot E; Petoumenos K; Swaminathan S; Withers B; Yun J; Polizzotto MN, 2023, 'Clinical and laboratory features of COVID-19 illness and outcomes in immunocompromised individuals during the first pandemic wave in Sydney, Australia', Plos One, 18, http://dx.doi.org/10.1371/journal.pone.0289907
Loprete J; Richardson R; Bramah V; Comben S; Li T; Beiglari L; O'Neill R; McEwan C; Carr A; Tong W; Campbell D; Wong M; Evans L; Post J; Torda A; Kane A; Kelleher A; Wainstein B; McMullan B; Law M, 2023, 'Delabeling, safety, and impact of β-lactam allergy testing: A systematic review', Journal of Allergy and Clinical Immunology Global, 2, pp. 100160, http://dx.doi.org/10.1016/j.jacig.2023.100160
Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Kelleher A; Templeton DJ; Zablotska-Manos I; Hoy J; McNulty A; Baker D; Brown G; Grulich A; Bavinton B, 2023, 'Agreements, Behaviour, and Change: Sex Outside the Relationship in Male HIV-negative Partners in HIV Serodiscordant Relationships in Australia, Brazil, and Thailand', AIDS and Behavior, 27, pp. 3098 - 3108, http://dx.doi.org/10.1007/s10461-023-04030-2
Brown SM; Barkauskas CE; Grund B; Sharma S; Phillips AN; Leither L; Peltan ID; Lanspa M; Gilstrap DL; Mourad A; Lane K; Beitler JR; Serra AL; Garcia I; Almasri E; Fayed M; Hubel K; Harris ES; Middleton EA; Barrios MAG; Mathews KS; Goel NN; Acquah S; Mosier J; Hypes C; Salvagio Campbell E; Khan A; Hough CL; Wilson JG; Levitt JE; Duggal A; Dugar S; Goodwin AJ; Terry C; Chen P; Torbati S; Iyer N; Sandkovsky US; Johnson NJ; Robinson BRH; Matthay MA; Aggarwal NR; Douglas IS; Casey JD; Hache-Marliere M; Georges Youssef J; Nkemdirim W; Leshnower B; Awan O; Pannu S; O'Mahony DS; Manian P; Awori Hayanga JW; Wortmann GW; Tomazini BM; Miller RF; Jensen JU; Murray DD; Bickell NA; Zatakia J; Burris S; Higgs ES; Natarajan V; Dewar RL; Schechner A; Kang N; Arenas-Pinto A; Hudson F; Ginde AA; Self WH; Rogers AJ; Oldmixon CF; Morin H; Sanchez A; Weintrob AC; Cavalcanti AB; Davis-Karim A; Engen N; Denning E; Taylor Thompson B; Gelijns AC; Kan V; Davey VJ; Lundgren JD; Babiker AG; Neaton JD; Lane HC; Tierney J; Vogel SE; McNay LA; Cahill K; Crew P; Sardana R; Segal Raim S; Shaw-Saliba K; Atri N; Miller M; Vallee D; Chung L; Delph Y, 2023, 'Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial', Lancet Respiratory Medicine, 11, pp. 791 - 803, http://dx.doi.org/10.1016/S2213-2600(23)00147-9
Bowden-Reid E; Ledger S; Zhang Y; Di Giallonardo F; Aggarwal A; Stella AO; Akerman A; Milogiannakis V; Walker G; Rawlinson W; Turville S; Kelleher AD; Ahlenstiel C, 2023, 'Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2', Antiviral Research, 217, http://dx.doi.org/10.1016/j.antiviral.2023.105677
Cysique LA; Jakabek D; Bracken SG; Allen-Davidian Y; Heng B; Chow S; Dehhaghi M; Staats Pires A; Darley DR; Byrne A; Phetsouphanh C; Kelleher A; Dore GJ; Matthews GV; Guillemin GJ; Brew BJ, 2023, 'The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC', Annals of Clinical and Translational Neurology, 10, pp. 1338 - 1352, http://dx.doi.org/10.1002/acn3.51825
Cross GB; Sari IP; Kityo C; Lu Q; Pokharkar Y; Moorakonda RB; Thi HN; Do Q; Dalay VB; Gutierrez E; Balanag VM; Castillo RJ; Mugerwa H; Fanusi F; Kwan P; Chew KL; Paton NI; Tumukunde D; Akol J; Quyet D; Nguyen H; Hoang XS; Doan TH; Barcelo M; Veto RGMS; Baliwagan MBR; Balane G; Geronimo A; Flores RR; Ng X; Tan S; Kelleher AD; Chang C, 2023, 'Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial', Lancet Infectious Diseases, 23, pp. 847 - 855, http://dx.doi.org/10.1016/S1473-3099(23)00067-1
Boyd MAA; Carey Hoppe A; Kelleher AD; Munier CML, 2023, 'T follicular helper cell responses to SARS-CoV-2 vaccination among healthy and immunocompromised adults', Immunology and Cell Biology, 101, pp. 504 - 513, http://dx.doi.org/10.1111/imcb.12635
van Bockel D; Kelleher A, 2023, 'The crossroads: divergent roles of virus-specific CD4+ T lymphocytes in determining the outcome for human papillomavirus infection', Immunology and Cell Biology, 101, pp. 525 - 534, http://dx.doi.org/10.1111/imcb.12650
Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fichter C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Britton W; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett NW; Darley D; Matthews G; Stark DJ; Petoumenos K; Rawlinson WD; Murrell B; Brilot F; Cunningham AL; Kelleher AD; Aggarwal A; Turville SG, 2023, 'Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level', Ebiomedicine, 90, http://dx.doi.org/10.1016/j.ebiom.2023.104545
Duette G; Cronin S; Kelleher AD; Palmer S, 2023, 'Viral competition assay to assess the role of HIV-1 proteins in immune evasion', STAR Protocols, 4, http://dx.doi.org/10.1016/j.xpro.2022.102025
Lundgren JD; Babiker AG; Sharma S; Grund B; Phillips AN; Matthews G; Kan VL; Aagaard B; Abo I; Alston B; Arenas-Pinto A; Avihingsanon A; Badal-Faesen S; Brites C; Carey C; Casseb J; Clarke A; Collins S; Corbelli GM; Dao S; Denning ET; Emery S; Eriobu N; Florence E; Furrer H; Fätkenheuer G; Gerstoft J; Gisslén M; Goodall K; Henry K; Horban A; Hoy J; Hudson F; Azwa RISR; Kedem E; Kelleher A; Kityo C; Klingman K; La Rosa A; Leturque N; Lifson AR; Losso M; Lutaakome J; Madero JS; Mallon P; Mansinho K; Filali KME; Molina J-M; Murray DD; Nagalingeswaran K; Nozza S; Ormaasen V; Paredes R; Peireira LC; Pillay S; Polizzotto MN; Raben D; Rieger A; Sanchez A; Schechter M; Sedlacek D; Staub T; Touloumi G; Turner M; Madruga JV; Vjecha M; Wolff M; Wood R; Zilmer K; Lane HC; Neaton JD; Group ISTOATS, 2023, 'Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection', NEJM Evidence, 2, pp. 10.1056/evidoa2200302, http://dx.doi.org/10.1056/evidoa2200302
Cook L; Zaunders J; Seddiki N; van Bockel D; Kelleher AD; Munier CML, 2023, 'Parallel analysis of multiple human memory CD4+ T-cell subsets within antigen-specific responses using cell proliferation dyes', Immunology and Cell Biology, 101, pp. 171 - 178, http://dx.doi.org/10.1111/imcb.12606
Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Klemm V; Munier CML; Hoppe AC; Tea F; Pillay A; Stella AO; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J, 2023, 'Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses', American Journal of Hematology, 98, pp. 131 - 139, http://dx.doi.org/10.1002/ajh.26619
Khoo WH; Jackson K; Phetsouphanh C; Zaunders JJ; Alquicira-Hernandez J; Yazar S; Ruiz-Diaz S; Singh M; Dhenni R; Kyaw W; Tea F; Merheb V; Lee FXZ; Burrell R; Howard-Jones A; Koirala A; Zhou L; Yuksel A; Catchpoole DR; Lai CL; Vitagliano TL; Rouet R; Christ D; Tang B; West NP; George S; Gerrard J; Croucher PI; Kelleher AD; Goodnow CG; Sprent JD; Powell JE; Brilot F; Nanan R; Hsu PS; Deenick EK; Britton PN; Phan TG, 2023, 'Tracking the clonal dynamics of SARS-CoV-2-specific T cells in children and adults with mild/asymptomatic COVID-19', Clinical Immunology, 246, http://dx.doi.org/10.1016/j.clim.2022.109209
Rankin K; Hastak P; Wong A; Sasson SC; Beaton B; Yeola A; Warden A; Turville S; Kelleher AD; Brilot F; Trotman J, 2023, 'Immune response to COVID‐19 vaccination in patients with Waldenström macroglobulinaemia who pause their BTKi therapy', eJHaem, 4, pp. 728 - 732, http://dx.doi.org/10.1002/jha2.724
Phetsouphanh C; Khoo WH; Jackson K; Klemm V; Howe A; Aggarwal A; Akerman A; Milogiannakis V; Stella AO; Rouet R; Schofield P; Faulks ML; Law H; Danwilai T; Starr M; Munier CML; Christ D; Singh M; Croucher PI; Brilot-Turville F; Turville S; Phan TG; Dore GJ; Darley D; Cunningham P; Matthews GV; Kelleher AD; Zaunders JJ, 2022, 'High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells', Frontiers in Immunology, 13, pp. 1032911, http://dx.doi.org/10.3389/fimmu.2022.1032911
Kristensen AB; Wragg KM; Vanderven HA; Lee WS; Silvers J; Kent HE; Grant MD; Kelleher AD; Juno JA; Kent SJ; Parsons MS, 2022, 'Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+NK cells in HIV-1-infected individuals', Clinical and Experimental Immunology, 210, pp. 163 - 174, http://dx.doi.org/10.1093/cei/uxac082
Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Stella AO; Kindinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Jean T; Foster CSP; Christ D; Hoppe AC; Munier ML; Darley D; Churchill M; Stark DJ; Matthews G; Rawlinson WD; Kelleher AD; Turville SG; Ruiz Silva M, 2022, 'SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern', Ebiomedicine, 84, pp. 104270, http://dx.doi.org/10.1016/j.ebiom.2022.104270
Hastak PS; Andersen CR; Kelleher AD; Sasson SC, 2022, 'Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.983550
Mylonakis E, 2022, 'Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 A Randomized Controlled Trial', Annals of Internal Medicine, 175, pp. 1266 - 1274, http://dx.doi.org/10.7326/M22-1503
Papot E; Jacoby S; Arlinda D; Avihingsanon A; Azwa I; Borok M; Brown D; Cisse M; Dao S; Eriobu N; Kaplan R; Karyana M; Kumarasamy N; Losso MH; Matthews GV; Perelis L; Perez-Casas C; Ruxrungtham K; Watkins M; Lane HC; Kelleher A; Law M; Polizzotto M, 2022, 'Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT', HIV Research & Clinical Practice, 23, pp. 37 - 46, http://dx.doi.org/10.1080/25787489.2022.2103572
Loprete J; Katelaris CH; Evans L; Kane A; McMullan B; Wainstein B; Wong M; Post J; Suan D; Swaminathan S; Richardson R; Rogers J; Torda A; Campbell DE; Kelleher AD; Law M; Carr A; Tong WWY; Toong C, 2022, 'Standardized testing and written communication improve patient understanding of beta-lactam allergy testing outcomes: A multicenter, prospective study', Journal of Allergy and Clinical Immunology Global, 1, pp. 99 - 105, http://dx.doi.org/10.1016/j.jacig.2022.05.003
Agbosu EE; Ledger S; Kelleher AD; Wen J; Ahlenstiel CL, 2022, 'Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection', Pharmaceutics, 14, http://dx.doi.org/10.3390/pharmaceutics14071352
Boyd MA; van Bockel D; Munier CML; Kelleher AD, 2022, 'Navigating the complexity of chronic HIV-1 associated immune dysregulation', Current Opinion in Immunology, 76, http://dx.doi.org/10.1016/j.coi.2022.102186
Aggarwal A; Stella AO; Walker G; Akerman A; Esneau C; Milogiannakis V; Burnett DL; McAllery S; Silva MR; Lu Y; Foster CSP; Brilot F; Pillay A; Van Hal S; Mathivanan V; Fichter C; Kindinger A; Hoppe AC; Munier ML; Amatayakul-Chantler S; Roth N; Coppola G; Symonds GP; Schofield P; Jackson J; Lenthall H; Henry JY; Mazigi O; Jäck HM; Davenport MP; Darley DR; Matthews GV; Khoury DS; Cromer D; Goodnow CC; Christ D; Robosa R; Starck DJ; Bartlett NW; Rawlinson WD; Kelleher AD; Turville SG; Ruiz Silva M, 2022, 'Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia', Nature Microbiology, 7, pp. 896 - 908, http://dx.doi.org/10.1038/s41564-022-01135-7
Self WH; Sandkovsky U; Reilly CS; Vock DM; Gottlieb RL; Mack M; Golden K; Dishner E; Vekstein A; Ko ER; Der T; Franzone J; Almasri E; Fayed M; Filbin MR; Hibbert KA; Rice TW; Casey JD; Hayanga JA; Badhwar V; Leshnower BG; Sharifpour M; Knowlton KU; Peltan ID; Bakowska E; Kowalska J; Bowdish ME; Sturek JM; Rogers AJ; Files DC; Mosier JM; Gong MN; Douin DJ; Hite RD; Trautner BW; Jain MK; Gardner EM; Khan A; Jensen JU; Matthay MA; Ginde AA; Brown SM; Higgs ES; Pett S; Weintrob AC; Chang CC; Murrary DD; Günthard HF; Moquete E; Grandits G; Engen N; Grund B; Sharma S; Cao H; Gupta R; Osei S; Margolis D; Zhu Q; Polizzotto MN; Babiker AG; Davey VJ; Kan V; Thompson BT; Gelijns AC; Neaton JD; Lane HC; Jundgren JD; Tierney J; Barrett K; Herpin BR; Smolskis MC; Voge SE; McNay LA; Cahill K; Crew P; Kirchoff M; Sardana R; Raim SS; Chiu J; Hensley L; Lorenzo J; Mock R; Shaw-Saliba K; Zuckerman J; Adam SJ; Currier J; Read S; Hughes E; Amos L; Carlsen A; Carter A; Davis B; Denning E; DuChene A; Harrison M; Kaiser P; Koopmeiners J; Meger S; Murray T; Quan K, 2022, 'Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial', Lancet Infectious Diseases, 22, pp. 622 - 635, http://dx.doi.org/10.1016/S1473-3099(21)00751-9
Kelleher AD, 2022, 'Pacific Eclipse: Before the corona dawn', Vaccine, 40, pp. 2474 - 2475, http://dx.doi.org/10.1016/j.vaccine.2021.02.021
Krishnan A; Ellenberger KA; Phetsouphanh C; Kelleher AP; Matthews GV; Darley DR; Holloway CJ, 2022, 'Myocardial fibrosis occurs in non-hospitalised patients with chronic symptoms after COVID-19', Ijc Heart and Vasculature, 39, http://dx.doi.org/10.1016/j.ijcha.2022.100964
Duette G; Hiener B; Morgan H; Mazur FG; Mathivanan V; Horsburgh BA; Fisher K; Tong O; Lee E; Ahn H; Shaik A; Fromentin R; Hoh R; Bacchus-Souffan C; Nasr N; Cunningham AL; Hunt PW; Chomont N; Turville SG; Deeks SG; Kelleher AD; Schlub TE; Palmer S, 2022, 'The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells', Journal of Clinical Investigation, 132, http://dx.doi.org/10.1172/JCI154422
Back to profile page
https://orcid.org/0000-0002-0009-3337